Lab-on-a-chip array could provide low-cost SARS-CoV-2 antibody test

By staff writers

August 24, 2020 -- The University of California, Irvine (UCI) has developed a low-cost lab-on-a-chip test called TinyArray that may be available for rapid COVID-19 diagnostic and antibody testing throughout the U.S. by the end of the year.

Developed by a research group spearheaded by Weian Zhao, PhD, the test uses blood from a finger-prick to probe hundreds of antibody responses to 14 respiratory viruses, including SARS-CoV-2, in two to four hours. Doing so could keep hospitals clear of patients with standard colds and flus.

The results are printed on the TinyArray imager, which combines a 3D-printed prototype with an off-the-shelf light-emitting diode (LED) and small 5-MP camera to find markers for many antibodies simultaneously. The platform has the accuracy of more expensive systems but is portable and costs only $200. Typically, similar systems that test for the full range of antibodies cost $10,000 to $100,000 and are too bulky for widespread use.

TinyArray can also process the results of nose swab tests for SARS-CoV-2 so that patients can be tested for COVID-19 and its antibodies on a single platform.

Zhao, a professor of pharmaceutical sciences at UCI, and colleagues, have already completed 5,000 tests in Orange County, with the final goal to test 20,000 samples per unit a day. UCI startups Velox Biosystems and Nanommune are partnering with the UCI research team to scale up production. They expect the TinyArray imager will be ready to ship nationwide by the end of the year and are working with scientists in Uruguay, Russia, and Thailand to develop similar systems.

Top 10 LabPulse stories for 1st half of 2020
It comes as no surprise that COVID-19 dominated the news for the first half of 2020, as evidenced in a list we compiled of the articles most viewed by...
World market outlook: COVID-19 testing evolves rapidly, lessons sink in
Worldwide, COVID-19 testing volume was on target to grow 25%-30% from May to June, reports Kalorama Information analyst Justin Saeks.
Physicians criticize U.K. antibody testing strategy
Medical and public health experts from the U.K. and Switzerland have come out against the quick rollout of COVID-19 antibody testing in England. The group...
Red Cross to test donated blood for COVID-19 antibodies
The American Red Cross has started testing blood, platelet, and plasma donations for COVID-19 antibodies.
AI-driven app uses blood biomarkers to flag high-risk COVID-19 patients
A new mobile app uses artificial intelligence (AI) to assess key biomarkers from blood tests and help clinicians identify patients who are most at-risk...

Copyright © 2020

Last Updated ls 8/24/2020 2:58:04 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current